RPA exhaustion induced by high levels of replication stress and NER deficiency promotes sensitivity to cisplatin in ovarian cancer cells, possibly by MRE11-mediated degradation of nascent ssDNA at stalled forks, and can be used as a strategy to treat cancer. The gene discussed is RPA1; the disease is cancer.